Answer
Patients with porphyria or a family history of porphyria are closely monitored because Pergoveris may increase the risk of an acute attack, and worsening or first appearance of porphyria may require stopping treatment.
Sources for this answer
- Pergoveris 150 IU/75 IU powder and solvent for solution for injectionMerck · emc · SmPC §4.4 Special warnings and precautions for use · Version 8Document updated
Sources checked